New Bismuth Germanate Oxide Nanoparticle Material for Biolabel Applications in Medicine

Figure 6

(a) Scattering of nonconjugated BGO nanoparticle. (b) Histograms of W6/32 conjugated BGO nanoparticles subsequently treated with fluorophore-conjugated anti-mouse IgG. A solution of nanoparticles without antibody was added as control.

(a)

(b)